12:00 AM
 | 
Feb 20, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

DNA IL-12: Phase II started

OncoSec said investigators began a single-arm, open-label, U.S. Phase II trial to evaluate intratumorally injected DNA IL-12 followed by in vivo electroporation using OncoSec's OMS...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >